NexImmune is one of Alexion's top competitors. NexImmune is a Public company that was founded in Gaithersburg, Maryland in 2011. NexImmune is in the Biotechnology field. NexImmune has 2,994 fewer employees vs. Alexion.
Alexion VS Coherus Oncology
Coherus Oncology is perceived as one of Alexion's biggest rivals. Coherus Oncology was founded in 2010 in Redwood City, California. Coherus Oncology competes in the Biotechnology industry. Coherus Oncology generates $6.2B less revenue than Alexion.
Alexion VS Regeneron
Regeneron is a top competitor of Alexion. Regeneron's headquarters is in Tarrytown, New York, and was founded in 1988. Regeneron competes in the Biotechnology field. Regeneron generates 246% of Alexion's revenue.
Regeneron will receive $1 billion upfront from Sanofi, with up to $7 billion more available through development, regulatory and commercial milestones...
Through a long-standing partnership with social innovators on the front lines of nutrition and health, Boehringer Ingelheim works to support communitie...
Nurix Therapeutics (NRIX) and Gilead Sciences (GILD) agreed to extend the research term for an undisclosed oncology program by two years, marking the s...
Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled by Alec...
AstraZeneca and Daiichi Sankyo have entered into a clinical collaboration agreement with Summit Therapeutics Inc. to evaluate Datroway (datopotamab der...
Novartis AG CH0012005267 - Pharmatechniker bedient eine industrielle Tablettenpresse in dokumentarischer Schwarzweißfotografie, Illustration mit AI ers...
AstraZeneca's tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) in two phase 3 trials,...
After a series of clinical-stage failures, Alector is resetting around its preclinical blood-brain barrier delivery technology, securing a big pharma p...
LONDON (dpa-AFX) - Summit Therapeutics Inc. (SMMT) on Monday announced the closing of AstraZeneca's (AZN) $2 billion strategic equity investment, which...
Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled by Alec...
Frequently Asked Questions about Alexion
Who are Alexion's top competitors?
Alexion's top 3 competitors are NexImmune, Coherus Oncology, Regeneron.
Who is similar to Alexion?
NexImmune is the most similar to Alexion. Coherus Oncology and Regeneron are also similar to Alexion.
Are Alexion and NexImmune competitors?
Yes, NexImmune is one of Alexion’s top competitors.